Co-author Aneel Banghu, consultant colorectal surgeon from the University of Birmingham, added: “Increased awareness and surveillance should be considered.
“At minimum, we suggest close adherence to routine standard VTE prophylaxis for surgical patients, including the use of anti-clotting medication when bleeding risk is minimal, and increased vigilance and diagnostic testing in patients presenting with signs of VTE, such as swelling in one calf, right-sided chest pain, and shortness of breath.”
Patients hospitalised with COVID-19 have previously been shown to have a high risk of VTE – between nine percent and six percent, despite the use of preventative drugs.
According to researchers at Ohio State University, COVID-19 can cause severe inflammation, which can trigger the body’s clotting system.
Credit: Source link